Cochleates, calcium-stabilized membrane rolls of nanoscale diameter, promise a unique and efficient way of delivering lipid-soluble drugs, proteins or nucleic acids into biological systems because they protect the encapsulated material against enzymatic or chemical degradation. Self-aggregation, which typically arises during production and storage is a major obstacle that has so far precluded the development of an efficient cochleate-based drug-delivery system. Here we show that citric acid, added transiently in a narrow concentration range, effectively disperses cochleate aggregates, stabilizes the disperse state for longterm storage and preserves the canonical ultrastructure and topological characteristics of cochleate nanoparticles.
Introduction
Cochleates are biocompatible, prospective drug-delivery vehicles. They are formed of spirally rolled bilayer sheets of negatively charged phospholipids stabilized by Ca 2+ ions [1] so that the lipidto-calcium binding ratio is thought to be 2:1 [1] [2] [3] . Several studies have shown their applicability as vaccine adjuvants [4] [5] [6] [7] [8] and carriers of antibiotics [9] [10] [11] [12] , systemic antimycotic agents [13] [14] [15] [16] or factor VII for replacement in hemophilia A [17, 18] . However, their widespread use is severely hindered by a major technological obstacle: Ca 2+ ions, which are essential in the formation and maintenance of cochleate structure, consistently provoke aggregation of the particles. Aggregation is a serious drawback as it prevents the efficient separation from byproducts, the assessment and monitoring of cochleate formation, the modification and functionalization of cochleate surface and the manufacturing of a disperse, longshelf-life pharmaceutical delivery system. A recent patent claimed to remedy this problem by adding half and half, milk, casein, albumin or methylcellulose [19] . However, the use of protein excipients may lead to aggravated problems of reduced stability and safety, and altered pharmacokinetics. Furthermore, methylcellulose caused only a partial disruption of aggregates. A long list of other polymeric materials (e.g., celluloses, gums, starches, etc.) has also been suggested as potential aggregation inhibitors, but feasibility is uncertain [19] . A very recent comparison between a novel, microfluidics-based strategy and conventional cochleate production methods has underlined that aggregation prevails as a major, unsolved problem [20] . In the present work we developed an efficient method of preparing stable, disperse cochleates. Dioleoyl phosphatidylserine liposomes, which are the precursors of cochleates, exhibit outstanding colloidal stability. However, upon the addition of Ca 2+ they quickly form aggregates. Aggregation is caused by the surface-charge-modifying effect of Ca 2+ [21] . Therefore, by removing calcium the aggregates are expected to disassemble into their component nanoparticles. Removal of calcium, however, may lead to unfavorable consequences, because it is the Ca 2+ ions themselves that stabilize the inner structure of cochleates. Indeed, it has been known since the discovery of cochleates that upon the addition of EDTA, a strong chelator of calcium, cochleate particles loose their rolled-up structure and fuse into giant vesicles [1] . We hypothesized that a molecule with an affinity to Ca 2+ lower than that of EDTA may be effective to dis- cochleates but leaving their inner structure intact. To test this hypothesis, we systematically examined sodium salts of mono-, bi-and tricarboxylic acids: acetate, tartrate and citrate. All of these acids are in their fully deprotonated form at pH 7.4, and their association constant to Ca 2+ increases with the number of their carboxyl groups (Table 1) . We show that the addition of sodium citrate in a narrow concentration regime can fully disperse aggregated cochleates, and after citrate removal a colloidally stable system is obtained in which the topology and ultrastructure of the nanoparticles are well preserved.
Materials and methods

Materials
Dioleoyl phosphatidylserine (1,2-Dioleoyl-sn-Glycero-3-[Phos pho-L-Serine], DOPS) was purchased from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). All other chemicals were from Sigma Aldrich Kft. (Budapest, Hungary).
Preparation of lipid vesicles and cochleates
Thin DOPS lipid film was formed on the wall of a clean glass tube by evaporating the organic solvent from 500 µl 20 mg/ml DOPS/chloroform stock solution under a stream of N 2 . Organic solvent traces were removed by placing the tube in vacuum (<20 Hgmm) for 30 min. The lipid film was then hydrated with 100 ll aliquots of 100 mM TRIS (pH 7.4) to 1 ml final volume while vigorously vortexing. This multilamellar vesicle (MLV) suspension was extruded 41 times through a polycarbonate membrane filter with 100 nm pore diameter in an AvantiPolar Mini Extruder (Avanti Polar Lipids, Inc., Alabaster, AL, USA). The resultant small unilamellar vesicle (SUV) suspension of 12.4 mM DOPS concentration was diluted 1 to 1 with 100 mM TRIS (pH 7.4), and 400 µl of this solution was dialyzed for 24 h against 100 ml 6.2 mM CaCl 2 , 100 mM TRIS (pH 7.4). The obtained cochleate suspension had a nominal 6.2 mM concentration for both DOPS and Ca 2+ . The sample was stored at room temperature until use. The preparatory steps were done at room temperature.
Dispersion of cochleates
Aqueous solutions of the tested potential dispersing agents (sodium acetate trihydrate, sodium tartrate dihydrate, trisodium citrate dihydrate, disodium edetate) were prepared in a buffer containing 100 mM TRIS (pH 7.4). We added 10 ll of the solution to 10 ll cochleate sample and mixed intensively by drawing through a narrow pipette tip 50 times. Samples were examined within 10 min after being mixed with dispersing agents. The actual concentrations of dispersing agents are given in figure captions. Control experiments were carried out with buffer only.
To obtain a stabilized colloidal system, 20 ll of cochleate sample freshly dispersed with citrate was diluted with 80 ll of 100 mM TRIS (pH 7.4), then clarified by centrifugation (Heraeus Biofuge Pico, Life Technologies Magyarország Kft., Budapest, Hungary, 12800g, at 25 ± 1°C, 5 min). The supernatant was gently removed and the pellet was resuspended in 90 ll of 100 mM TRIS (pH 7.4). The procedure was repeated 3 times. To test the effect of Ca 2+ on resuspended cochleates, the pellets were resuspended with 100 mM TRIS (pH 7.4) containing 6.2 mM CaCl 2 .
Phase contrast microscopy
Micrographs were recorded with a Nikon Eclipse Ti-U inverted microscope (Auro-Science Kft., Budapest, Hungary) equipped with a uEye UI 1220 LE digital camera (IDS Imaging Development Systems GmbH, Obersulm, Germany) using either a 20x or a 40x Nikon S Planfluor phase contrast objective.
Atomic force microscopy
For AFM imaging 10 µl of the control or dispersed cochleate sample was diluted with 50 µl 100 mM TRIS (pH 7.4) then applied to the substrate and, after 1 min incubation, washed gently with MilliQ water and dried in a stream of N 2 gas. For control cochleates freshly cleaved mica sheets were used as substrate. In the case of dispersed cochleates we used mica sheets pre-coated with 100 ll 0.01% poly-L-lysine for 20 min. Cochleates were imaged with a Cypher instrument (Asylum Research, Santa Barbara, CA) with 0.5-2.5 Hz line-scanning rate in air at 29 ± 1°C. A silicon cantilever (OMCL AC-160TS, Olympus, Japan) was used in non-contact mode, oscillated at its resonance frequency (300-320 kHz, typically). Images with 512 Â 512 pixel dimensions were collected and analyzed with the built-in algorithms of the AFM driver software.
Small-angle X-ray scattering
Small-angle X-ray scattering (SAXS) measurements on the cochleate samples were carried out with a CREDO instrument integrated with a GeniX 3D Cu ULD microfocus system (Xenocs SA, Sassenage, France) for producing X-rays and a Pilatus-300 k CMOS hybrid pixel position sensitive detector (Dectris Ltd, Baden, Switzerland) [22, 23] . The recorded 2D scattering patterns were subjected to the standard on-line data reduction procedure of the instrument control software. Corrections were made for instrumental background, detector flatness, and sample self-absorption. The abscissa was calibrated with mesoporous silica into scattering
, where 2h is the scattering angle and k = 0.154 nm is the X-ray wavelength of Cu Ka radiation. Intensity was transformed from count rates to differential scattering cross-section (cm À1 Ásr À1 ) units using a pre-calibrated glassy carbon specimen. The MLV sample was used without further processing. Cochleate samples were clarified by centrifugation (see above). All the samples were filled into borosilicate capillaries of cca. 1 mm outer diameter and 0.01 mm wall thickness and centrifuged gently (Eppendorf Minispin microcentrifuge, Eppendorf AG, Hamburg, Germany, 67g; at 25 ± 1°C, 5 min) to prevent sedimentation during experiment. The total exposure time was at least 2 h in each case, carried out in several 5-min exposures in order to monitor sample stability.
Infrared spectroscopy
ATR-FTIR spectra were collected with a Varian 2000 FTIR Scimitar Series (Varian Inc., Paolo Alto, CA) spectrometer equipped with a 'GoldenGate' (Specac Ltd., London, UK) single reflection diamond ATR accessory. The measurements were performed at room temperature: 5 ll sample was mounted on the top of the diamond ATR crystal. DOPS SUV sample was applied directly, while cochleate samples were clarified by centrifugation (see at dispersion of cochleates) and once more centrifuged at 12800g for 5 min. The supernatant was removed and the resuspended pellet was used. IR spectra were recorded both on hydrated lipid systems and as dry films obtained on diamond ATR surface after solvent evaporation. We collected 128 scans at a resolution of 2 cm
À1
. ATR correction was executed after each data collection. All spectral manipulations were performed using the GRAMS/32 software package (Galactic Industries Incorporation, USA).
Results and discussion
Standard cochleate preparation yields aggregates
Upon the addition of calcium to DOPS vesicles a milky suspension formed that contained micron-size aggregates of irregular shape (Fig. 1A) . Elongated objects identified as cochleates protruded from the aggregates the bulk of which consisted of aggregated vesicles (Fig. 1B and Supplement Fig. 1 ). Cochleates and vesicles were strongly bound to each other and could not be dispersed by either dilution or intense shaking (Supplement Fig. 2 ).
Citrate disperses aggregates
To test the hypothesis that a molecule with appropriate affinity to Ca 2+ may be effective to disperse aggregates, we added different carboxylic acids to cochleate samples. These acids are fully deprotonated at pH 7.4, and their affinity to Ca 2+ increases with the number of their carboxyl groups (Table 1) . Acetate did not cause any disassembly of the aggregates even at a concentration of 500 mM (Supplement Fig. 3A) . Treatment with 500 mM tartrate led only to a partial disassembly (Supplement Fig. 3B ). By contrast, citrate effectively dispersed the cochleates ( Fig. 2A) . Furthermore, the dispersing effect of citrate was concentration-dependent (Supplement Fig. 4 ). At the given experimental lipid and Ca 2+ concentrations the optimal citrate concentration range was 200-212.5 mM. Below this concentration regime aggregates disassembled only partially, while above this regime the cochleates transformed into giant vesicles (Supplement Fig. 4) . Thus, there is a relatively narrow concentration range in which citric acid functions as an efficient dispersing agent of cochleate-vesicle aggregates.
3.3. Assurance of long-term cochleate stability Fig. 2B . shows a cochleate sample 24 h after it was dispersed by citrate. Individual cochleates, which were clearly distinguishable after citrate addition ( Fig. 2A) , were no longer observed. Rather, they transformed into clusters of giant vesicles. Thus, citrate, even when applied in the optimal dispersing concentration, disintegrates cochleates with time by extracting the calcium ions from in between the membrane layers. To avoid this effect, we removed excess citrate by centrifuging the sample immediately following the complete dispersion of cochleates then resuspended the pellet in 100 mM TRIS (pH 7.4). The cochleates in this sample preserved their structure, and, although sedimented with time, by stirring they could be well dispersed even after one month of storage at 25 ± 1°C (Fig. 2C) . If Ca 2+ concentration was restored in the , citrate treatment altered the surface properties of cochleates and thereby prevented their aggregation.
Citrate treatment preserves the high-resolution structure of cochleates
To test whether the cylindrical particles found in the citratetreated samples ( Fig. 2A and C) preserved the canonical cochleate structure, we carried out high-resolution AFM measurements. We were unable to discern any appreciable structural differences between the control (Fig. 1B and Supplement Fig. 1 ) and citratetreated cochleate particles ( Fig. 3 and Supplement Fig. 6 ). Both control and citrate-stabilized cochleates displayed features consistent with their presumed cochleate model [1, 29, 30] . Accordingly, both samples contained elongated particles with gradually varying diameter across their longitudinal axis. The edges of lipid layers were clearly seen on their surface indicating a roll-like arrangement. There was only one striking difference between the samples: whereas in control samples the cochleates were often part of an aggregate composed of roll-like and vesicular structures (Fig. 1B and Supplement Fig. 1 ), in the citrate-treated sample the particles were systematically dispersed ( Fig. 3 and Supplement Fig. 6 ). Thus, citrate can effectively disperse cochleates without damaging their unique structure.
Although the citrate-treated and control cochleates are topologically essentially identical, ultrastructural differences might be present. To explore the effect of citrate on the internal structure of cochleates we used small-angle X-ray scattering (SAXS) which can reveal the changes in correlation and ordering of vicinal bilayers. Scattering was measured in an interval corresponding to the range of bilayer thickness and periodicity (0.3-6 nm
À1
). The investigated samples were a DOPS multilamellar vesicle suspension, a control sample with aggregated cochleate particles, another two with 100 mM and 212.5 mM citrate, and finally one containing 50 mM EDTA instead of citrate (Fig. 4) . Notably, at a citrate concentration of 100 mM cochleates were partially dispersed, while at 212.5 mM dispersion was complete (Supplement Fig. 4 ) and the addition of 50 mM EDTA led to the transformation of cochleates into giant vesicles (Supplement Fig. 7) . The hydrated DOPS system, which is expected to form multilamellar vesicles, shows a very broad signal between 0.5 nm À1 < q < 3 nm À1 (Fig. 4A ) typical for entirely uncorrelated multilamellar systems [31] . The absence of long-range ordering is caused by the electrostatic repulsion of the neighbouring bilayers due to the net negative charge of the phosphatidylserine headgroups. The addition of Ca 2+ caused a drastic change in the layer organization as seen from the sharp, equidistant Bragg-reflections at 1.2, 2.4 and 3.77 nm À1 (Fig. 4B) .
The highly ordered and periodic lamellar state corresponds to the cochleate and has a repeat distance of 5.15 nm, similarly to the findings of Nagarsekar et al. [20] . This structure is retained even following the addition of citrate ( Fig. 4C and D) . The peak positions align well with the control cochleate sample and correspond to a 5.18 nm repeat distance. The observed loss in intensity was likely caused by the different sedimentation rate of samples which resulted in different amounts of lipid material in the lower region of the capillaries where the X-ray beam was focused. At high citrate concentration the SAXS signal monotonically increases towards small angle intervals, which is attributed to the diffuse scattering by the smaller particles emerging during the disaggregation process (Fig. 4D) . This feature was absent in control cochleate (Fig. 4B ) and cochleate + 100 mM citrate (Fig. 4C) samples, because the scattering by the large aggregates made little contribution in this region. The addition of EDTA induced significant changes in bilayer structure (Fig. 4E) . The overall scattering curve resembles that of uncorrelated bilayers, and a single Bragg peak at 0.92 nm À1 appeared. This reflection corresponds most likely to the small amount of regular multilamellar bilayer stacks present in the system. The periodicity (6.8 nm) is significantly greater than that in cochleates (5.15 nm) indicating that layer packing is less tight than in cochleates. In summary, applying citrate at a concentration optimal to disperse aggregated cochleates does not modify the inner structure of the membrane rolls. 
Citrate removes Ca 2+ from cochleate-surface head groups
To reveal the molecular mechanisms of the dispersing effect of citrate, we carried out infrared spectroscopy measurements with a focus on the phosphate (1250-100 cm , respectively, were rather featureless for the DOPS SUV system (Fig. 5A, spectrum a) . In control cochleates the PO 2 À asymmetric stretching band shifted from 1219 to 1236 cm À1 and the symmetric PO 2 À stretching band split to four components (1111, 1102, 1075 and 1063 cm À1 , Fig. 5A , spectrum b). These changes point at the dehydration of the phosphate group and the formation of a bidentate complex between the Ca 2+ ion and the phosphate ester [32] . Addition of 100 mM citrate did not cause any spectral changes in the phosphate head group region (Fig. 5A , spectrum c). At 212.5 mM citrate concentration the relative intensities of phosphate stretching bands, characteristic to Ca 2+ -DOPS interaction, decreased (Fig. 5A, spectrum d , respectively (Fig. 5B, spectrum a) . In control cochleates the methylene stretching band positions shifted towards lower wavenumbers (Fig. 5B, spectrum b) indicating a tighter lipid packing, which may be attributed to the strong interaction of Ca 2+ with lipid head groups. Addition of 100 mM citrate had no observable effect in this spectral region (Fig. 5B , spectrum c). However, at a dispersing citrate concentration (212.5 mM) the position of both the asymmetric and symmetric stretching bands shifted to higher wavenumbers approaching those of the Ca 2+ -free liposomes (Fig. 5B, spectrum d) . Thus, a fraction of lipids became less tightly packed. Upon adding 50 mM EDTA a further increase of m s CH 2 could be observed as a result of acyl-chain perturbation leading to a lipid bilayer structure, the packing of which is similar to that of liposomes (Fig. 5B , spectrum e). In the spectral region sensitive to ester carbonyl vibrations, DOPS liposomes (Fig. 5C, spectrum a) (Fig. 5C, spectrum b) . The lower wavenumbers point at the formation of new hydrogen bonds, while band narrowing is due to a significant reduction in motional freedom caused most likely by the immobilization of polar headgroups due to Ca 2+ complexation [34, 35] . Addition of 100 mM citrate did not alter the IR spectrum (Fig. 5C , spectrum c). At the dispersing citrate concentration (212.5 mM), however, the intensities of the narrow mC = O stretching bands, peculiar to the Ca 2+ -DOPS complexes, decreased, and a broad band centered at 1728 cm À1 , characteristic to hydrated DOPS lipids, appeared (Fig. 5C, spectrum d) . Upon the addition of 50 mM EDTA the carbonyl stretching region of the IR spectrum reverted back to that of DOPS liposomes, and the spectral features characteristic to cochleates disappeared (Fig. 5C , spectrum e). Similar trends were observed in dry film spectra (Supplement Fig. 8) with the exception that the narrow mC = O stretching bands, specific to Ca 2+ -bound phospholipids, were more dominant even at 212.5 mM citrate (Supplement Fig. 8d) . Because under dry film conditions the direct interactions are more important, these bands underpin that Ca 2+ -bound head groups were present even after the addition of 212.5 mM citrate. Altogether the FTIR spectroscopy results indicate that citrate applied in dispersing concentration removes Ca 2+ from a fraction of the lipid head groups. Since cochleates with preserved structure prevailed (Figs. 2 and 3 ) and FTIR spectra also showed the presence of Ca 2+ -head group complexes in citrate-dispersed samples (Fig. 5, spectra d) , the Ca 2+ -deprived fraction may correspond to both the head groups of vesicles and cochleate-surface head groups. Nevertheless, within the dispersing citrate concentration range, the calcium-bound state of the internal lipid head groups of cochleates is left intact. Notably we cannot exclude that some cochleates disintegrated upon addition of citrate at optimal dispersing concentration. This may happen due to local concentration inhomogeneities during mixing the sample with citrate.
Conclusions
In conclusion, citric acid, an inexpensive, low-molecular-weight and biocompatible material, can be effectively used as a dispersing and stabilizing agent in cochleate nanotechnology. Citrate apparently removes Ca 2+ from the cochleate surface rapidly and disrupts calcium-dependent cross-links between the particles. Removal of cross-links and an increased electrostatic repulsion between the particles leads to the rapid disassembly of aggregates. By contrast, it takes a longer time for citrate to extract Ca 2+ incorporated between the membrane layers. Therefore, the unrolling of cochleates can be prevented by removing excess citrate following aggre- gate disassembly. Altogether, a disperse cochleate sample with long-term stability is obtained. The citrate-based dispersion and stabilization method is likely to contribute to the development of efficient cochleate-based drug delivery systems.
